Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Vitamin C

This article was originally published in The Tan Sheet

Executive Summary

Regular supplement use is associated with 40% reduced risk of noncardia gastric cancer, researchers report in October Cancer Epidemiology, Biomarkers & Prevention. Supplemental and dietary vitamin C were found to significantly lower risk of four tumor types (esophageal adenocarcinoma, gastric cardia adenocarcinoma, esophageal squamous cell carcinoma and noncardia gastric adenocarcinoma), Susan Mayne, Yale University, et al., report. Researchers find no link between multivitamins, risk of tumor type. Case-controlled study included 1,839 persons in Connecticut, New Jersey, Washington diagnosed with one of the four tumors. Subjects were asked about food consumption, supplementation patterns; research was supported by NCI grant...

You may also be interested in...

Labor/HHS approps

Senate bill passes 89-10 Nov. 6 with measure that would provide NIH Office of Dietary Supplements with up to $20 mil. to "continue and expand" ephedra safety/efficacy research, botanical research centers. HR 3061 also allocates $110 mil. to NCCAM for FY 2002; House version, which passed Oct. 11, offers $99.3 mil. for NIH center. Senate bill includes amendment by Sens. Orrin Hatch (R-Utah), Tom Harkin (D-Iowa) providing $500,000 to cover labeling enforcement under DSHEA, language urging publication of supplement GMPs within 15 days of bill enactment (1"The Tan Sheet" Nov. 5, In Brief). Conferees, including Harkin, likely will meet week of Nov. 12 to reconcile differences...

Germany's OTC Market in 2019: Stagnation Overall, Online Growth Continues

A weak cough and cold season in Germany last winter held back OTC sales growth in 2019, according to IQVIA, while the country's online pharmacy channel continued to expand. 

Stockwatch: Choppy Waters For Teva And Bausch

After most of the big pharmaceutical companies reported their full-year 2019 financial results, the second month of earnings season brings the long tail of smaller biotech companies and the generic pharmaceutical companies. There is more than one uncomfortable parallel from the former in the reports of the latter.







Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts